Visikol and Corning Team Up on 3D Cell Culture Tutorial
Mike Johnson2019-06-06T06:56:42-05:00This week at the Society for Laboratory Automation and Screening conference in San Diego Dr. Thomas Villani from Visikol and [...]
Visikol Presents Keynote Talk at Abcam Biomarker Platforms and Biomarkers in Immuno-Oncology Conference on Advanced 3D In Vitro Drug Discovery Services
Mike Johnson2019-02-21T02:49:15-05:00Full PRWEB Press Release Can Be Read It This Link Visikol, a leader in phenotypic drug discovery and advanced imaging [...]
Visikol CEO and Co-Founder Dr. Michael Johnson Interviewed in SciWri
Mike Johnson2019-02-21T01:30:51-05:00Michael recently sat down with Rituparna Chakrabarti from SciWri and discussed all things entrepreneurship. Check out the in depth full [...]
Visikol Launches Improved Visikol® HISTO-M™ Reagent for the Visualization of 3D Cell Culture Models
Mike Johnson2019-07-23T08:36:06-05:00As a drug discovery contract research organization, Visikol is committed to providing enhanced in vitro assays that reduce the [...]
JoVE Video Publication on Visikol HISTO for Placenta Vasculature Visualization
Mike Johnson2019-07-23T08:37:07-05:00Visikol recently published a tutorial video presentation in JoVE on the use of Visikol HISTO tissue clearing for human [...]
Visikol Names Brian Mulhall as Director of Corporate Development
Mike Johnson2019-02-21T01:30:52-05:00Expected to play a key role in the partnership formation for the company’s drug discovery services which leverage their patented [...]
Visikol Launches Market’s First Suite of 3D Histopathology Services
Mike Johnson2019-07-24T13:47:18-05:00NEW BRUNSWICK, N.J. (PRWEB) APRIL 15, 2018 For as little as $500 per tissue sample, Visikol is now offering 3D [...]
Visikol Sponsors NIH 3D Retina Organoid Competition
Mike Johnson2019-02-21T02:49:15-05:00As a company focused on three-dimensional tissue imaging, digital pathology and advanced in vitro models, we have been very focused [...]
Visikol Accelerates Growth with Relocation to New Facility
Mike Johnson2019-02-21T01:30:52-05:00WHITEHOUSE, N.J. (PRWEB) MAY 14, 2018 The move is a key milestone that will enable the company to expand its [...]
Visikol Launches Oncology Drug Screening Services Through its 3Screen™ Portfolio
Mike Johnson2019-07-24T13:47:20-05:00WHITEHOUSE, N.J. (PRWEB) JUNE 6, 2018 Recently, Visikol, a contract research organization focused on digital pathology and optical imaging built [...]